![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[Article Abstract]](/e/graphics/abstractborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](si2220contents.gif)
Acta Cryst. (2009). E65, m1579 [ doi:10.1107/S1600536809047345 ]
![[mu]](/logos/entities/mu_rmgif.gif)
2-5-methylpyrazine-2-carboxylato)-1:2![[kappa]](/logos/entities/kappa_rmgif.gif)
3N1,O:O;2:33O:N1,O;1:22O:O';3:42O:O'-octaoctyl-12C,22C,32C,42C-di-3-oxido-1:2:33O;1:3:43O-tetratin(IV)Online 14 November 2009
Copyright © International Union of Crystallography
IUCr Webmaster